- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 15, 2026 | 309.72M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 309.72M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 299.95M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 286.47M sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 285.01M sh |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | −$527K |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | −$624K |
| Long Term Debt | Q3 2026 · Mar 31, 2026 | $150K |
| Long Term Debt | Q3 2026 · Jun 30, 2025 | $150K |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $45K |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $249K |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | −$467K |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | −$248K |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $69K |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $299K |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | −$23K |
| Stockholders Equity | Q3 2026 · Jun 30, 2024 | −$480K |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $383K |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $78K |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $533K |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $228K |
| Current Assets | Q3 2026 · Mar 31, 2026 | $55K |
| Current Assets | Q3 2026 · Jun 30, 2025 | $286K |
| Total Assets | Q3 2026 · Mar 31, 2026 | $66K |
| Total Assets | Q3 2026 · Jun 30, 2025 | $297K |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | $0.00 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $234K |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $949K |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $283K |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $847K |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $11K |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $42K |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $66K |
| Net Income | Q3 2026 · Mar 31, 2026 | −$219K |
| Net Income | Q3 2026 · Mar 31, 2026 | −$953K |
| Net Income | Q3 2026 · Mar 31, 2025 | −$230K |
| Net Income | Q3 2026 · Mar 31, 2025 | $122K |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$231K |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$954K |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$228K |
| Operating Income | Q3 2026 · Mar 31, 2025 | −$753K |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $3K |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $6K |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $97K |
| Gross Profit | Q3 2026 · Mar 31, 2025 | $160K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $0 |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $0 |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $25K |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $38K |